Pharmacological studies on OKY-1581: a selective thromboxane synthetase inhibitor.
D000179:Acrylates / Q000494:pharmacology*; D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000633:toxicity; D001241:Aspirin / Q000494:pharmacology; D001681:Biological Assay; D001792:Blood Platelets / Q000201:enzymology; D002544:Cerebral Infarction / Q000139:chemically induced; D000882:Haplorhini; D007700:Kinetics; D008689:Methacrylates / Q000494:pharmacology*; D009119:Muscle Contraction / Q000187:drug effects; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D010974:Platelet Aggregation / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D013927:Thrombosis / Q000139:chemically induced; D013928:Thromboxane A2 / Q000494:pharmacology; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
D000179:Acrylates; D001095:Arachidonic Acids; D008689:Methacrylates; D016718:Arachidonic Acid; D013928:Thromboxane A2; C031517:2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid; D010088:Oxidoreductases; D013930:Thromboxane-A Synthase; D001241:Aspirin